94.16
price up icon1.00%   0.93
pre-market  Vorhandelsmarkt:  95.09   0.93   +0.99%
loading
Schlusskurs vom Vortag:
$93.23
Offen:
$93.815
24-Stunden-Volumen:
2.93M
Relative Volume:
1.35
Marktkapitalisierung:
$13.93B
Einnahmen:
$4.34B
Nettoeinkommen (Verlust:
$-965.00M
KGV:
-15.51
EPS:
-6.07
Netto-Cashflow:
$869.00M
1W Leistung:
+4.32%
1M Leistung:
+17.16%
6M Leistung:
-30.23%
1J Leistung:
-10.90%
1-Tages-Spanne:
Value
$92.76
$95.99
1-Wochen-Bereich:
Value
$88.67
$95.99
52-Wochen-Spanne:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Firmenname
Illumina Inc
Name
Telefon
(858) 202-4500
Name
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Mitarbeiter
8,970
Name
Twitter
@illumina
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ILMN's Discussions on Twitter

Vergleichen Sie ILMN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
ILMN
Illumina Inc
94.16 13.93B 4.34B -965.00M 869.00M -6.07
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
412.12 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.46 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
527.78 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.42 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.16 27.64B 15.50B 1.33B 2.16B 7.34

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-04 Bestätigt Citigroup Neutral
2025-02-28 Herabstufung HSBC Securities Buy → Hold
2025-02-10 Herabstufung Barclays Equal Weight → Underweight
2025-02-07 Herabstufung TD Cowen Buy → Hold
2024-12-11 Herabstufung Citigroup Buy → Neutral
2024-11-12 Fortgesetzt Morgan Stanley Equal-Weight
2024-10-17 Hochstufung HSBC Securities Hold → Buy
2024-08-28 Hochstufung Argus Hold → Buy
2024-08-16 Hochstufung Daiwa Securities Neutral → Buy
2024-08-14 Hochstufung Barclays Underweight → Equal Weight
2024-08-14 Hochstufung TD Cowen Hold → Buy
2024-07-10 Hochstufung Citigroup Neutral → Buy
2024-06-03 Fortgesetzt Jefferies Hold
2024-01-16 Herabstufung HSBC Securities Buy → Hold
2024-01-04 Herabstufung TD Cowen Outperform → Market Perform
2023-12-18 Hochstufung Scotiabank Sector Perform → Sector Outperform
2023-12-15 Hochstufung Bernstein Underperform → Mkt Perform
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-14 Eingeleitet Stephens Overweight
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Herabstufung BofA Securities Neutral → Underperform
2023-12-11 Hochstufung Citigroup Sell → Neutral
2023-11-10 Herabstufung Canaccord Genuity Buy → Hold
2023-09-28 Eingeleitet Bernstein Underperform
2023-07-05 Fortgesetzt JP Morgan Neutral
2023-01-25 Herabstufung Argus Buy → Hold
2023-01-05 Eingeleitet Scotiabank Sector Perform
2022-12-12 Herabstufung Citigroup Neutral → Sell
2022-12-07 Eingeleitet RBC Capital Mkts Outperform
2022-10-04 Hochstufung SVB Leerink Mkt Perform → Outperform
2022-09-28 Hochstufung Evercore ISI In-line → Outperform
2022-08-25 Eingeleitet Credit Suisse Neutral
2022-07-13 Herabstufung Barclays Equal Weight → Underweight
2022-01-18 Hochstufung Stifel Hold → Buy
2022-01-11 Hochstufung Barclays Underweight → Equal Weight
2022-01-07 Hochstufung BofA Securities Underperform → Neutral
2022-01-06 Fortgesetzt Morgan Stanley Equal-Weight
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-19 Herabstufung SVB Leerink Outperform → Mkt Perform
2021-06-01 Hochstufung Evercore ISI Underperform → In-line
2021-03-31 Herabstufung Atlantic Equities Overweight → Neutral
2021-03-31 Hochstufung Canaccord Genuity Hold → Buy
2021-03-03 Eingeleitet Barclays Underweight
2020-12-22 Hochstufung Piper Sandler Neutral → Overweight
2020-12-17 Hochstufung BTIG Research Neutral → Buy
2020-10-13 Herabstufung Guggenheim Buy → Neutral
2020-09-30 Eingeleitet Atlantic Equities Overweight
2020-09-29 Herabstufung Wolfe Research Outperform → Peer Perform
2020-09-22 Herabstufung Stifel Buy → Hold
2020-09-22 Herabstufung UBS Buy → Neutral
2020-09-21 Hochstufung Guggenheim Neutral → Buy
2020-09-21 Herabstufung JP Morgan Overweight → Neutral
2020-09-09 Eingeleitet Morgan Stanley Equal-Weight
2020-08-07 Herabstufung Evercore ISI In-line → Underperform
2020-08-07 Herabstufung Piper Sandler Overweight → Neutral
2020-07-07 Herabstufung Guggenheim Buy → Neutral
2020-04-24 Herabstufung Citigroup Buy → Neutral
2020-04-21 Herabstufung Robert W. Baird Outperform → Neutral
2020-01-08 Eingeleitet Wells Fargo Underweight
2020-01-07 Eingeleitet Citigroup Buy
2020-01-02 Herabstufung Evercore ISI Outperform → In-line
2019-11-15 Eingeleitet Stifel Buy
2019-10-25 Eingeleitet Guggenheim Buy
Alle ansehen

Illumina Inc Aktie (ILMN) Neueste Nachrichten

pulisher
Jun 18, 2025

Infinity Bio Secures $8M Series A and Acquires Serimmune to Dominate Antibody Reactome Market - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

DNA/Gene Microarray Market Future Trends and Scope Analysis - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

How the DNA Data Storage Market Will Evolve by 2032Growth, - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025 - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 14, 2025

Next-Gen Diagnostics Drive Biochips Market Growth: Thermo Fisher, Illumina, and PerkinElmer at the Forefront - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Illumina and Science Centre Singapore partner for Brain Fest 2025 - Illumina

Jun 13, 2025
pulisher
Jun 12, 2025

Video: Inspiring the next generation of scientists in Singapore - Illumina

Jun 12, 2025
pulisher
Jun 12, 2025

Clinical Oncology Next Generation Sequencing Market Detailed - openPR.com

Jun 12, 2025
pulisher
Jun 11, 2025

Illumina (ILMN) Price Target Boosted by Canaccord Analyst | ILMN Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Video: Two Illumina scientists share their “why” - Illumina

Jun 11, 2025
pulisher
Jun 11, 2025

Breaking Down Illumina: 11 Analysts Share Their Views - Benzinga

Jun 11, 2025
pulisher
Jun 10, 2025

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - Illumina

Jun 10, 2025
pulisher
Jun 10, 2025

Lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

Piper Sandler maintains Illumina stock Overweight, $185 target By Investing.com - Investing.com UK

Jun 09, 2025
pulisher
Jun 09, 2025

Long Read Sequencing Market Top Key Players Analysis - openPR.com

Jun 09, 2025
pulisher
Jun 07, 2025

Gemeinsam Genomik neu denken - Illumina

Jun 07, 2025
pulisher
Jun 07, 2025

Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf - openPR.com

Jun 07, 2025
pulisher
Jun 06, 2025

Single-cell Omics Market Projected to Witness Growth with - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Tumor-Derived Exosomes Market Set to Witness Significant - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Hereditary Testing Market Future Business Opportunities - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com

Jun 06, 2025
pulisher
Jun 05, 2025

Does Illumina (ILMN) Have Good Long-Term Growth Prospects? - Insider Monkey

Jun 05, 2025
pulisher
Jun 05, 2025

Nucleic Acid Isolation and Purification Market Size, Trends & - openPR.com

Jun 05, 2025
pulisher
Jun 04, 2025

Illumina’s DNA Test Tech Infringes Hospital Patent, Suit Claims - Bloomberg Law News

Jun 04, 2025
pulisher
Jun 04, 2025

Microbiome Sequencing Market Outlook 2025-2029 | Affordable Sequencing Instruments Expand Market Access for Smaller Labs - Yahoo

Jun 04, 2025
pulisher
Jun 04, 2025

Digital Genome Market Deep Research Report on AI-Driven DNA Analysis Trends | Illumina, Thermo Fisher Scientific - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.

Jun 04, 2025
pulisher
Jun 03, 2025

Cancer Profiling Market Is Booming So Rapidly 2025-2032 - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

Hereditary Testing MarketGlobal Industry Trends, Opportunity, and Forecast, 2020-2030: Key Players Like Illumina and Myriad Genetics Leading the Charge - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Next-Gen RNA Sequencing Market | Personalized Medicine & Future - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Gene Panel Market Projected to Witness Massive GrowthIllumina, Inc., Thermo Fisher Scientific - openPR.com

Jun 02, 2025
pulisher
May 31, 2025

Illumina Connected Insights - Technology Networks

May 31, 2025
pulisher
May 30, 2025

Illumina Inc (ILMN) Stock Price Down 3.31% on May 30 - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Genotyping Assay Market Deep Research Report Highlights Key AdvancementsIllumina, Thermo Fisher Scientific - openPR.com

May 30, 2025
pulisher
May 30, 2025

Illumina’s PromoterAI unlocks rare disease clues in noncoding genome - statnews.com

May 30, 2025
pulisher
May 30, 2025

Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Epigenetics Market Analysis 2025-2033: Advances in DNA - openPR.com

May 30, 2025
pulisher
May 30, 2025

Illumina introduces PromoterAI for rare disease diagnosis By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Illumina Inc.: Tackling Global Headwinds With Strategic Market Diversification! - Smartkarma

May 30, 2025
pulisher
May 29, 2025

Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis - Insider Monkey

May 29, 2025
pulisher
May 29, 2025

Illumina introduces PromoterAI for rare disease diagnosis - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Operating a speedy, high-tech NGS lab in remote Australia - Illumina

May 29, 2025
pulisher
May 29, 2025

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Bioinformatics Market Detailed in New Research ReportThermo Fisher Scientific, Illumina - openPR.com

May 29, 2025
pulisher
May 29, 2025

DNA giant Illumina spawned an ecosystem of competitors and customers - Endpoints News

May 29, 2025
pulisher
May 29, 2025

Illumina widens access to cancer tests with Medicare and new CDx - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Patent Fight Breaks Out over Genetic Sequencing - Orthopedics This Week

May 28, 2025
pulisher
May 28, 2025

Illumina at Bernstein Conference: Strategic Insights and Challenges - Investing.com

May 28, 2025

Finanzdaten der Illumina Inc-Aktie (ILMN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Illumina Inc-Aktie (ILMN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Thaysen Jacob
Chief Executive Officer
May 12 '25
Buy
80.88
6,500
525,732
77,540
Thaysen Jacob
Chief Executive Officer
May 13 '25
Buy
80.84
5,850
472,942
83,390
diagnostics_research DGX
$177.06
price down icon 0.89%
diagnostics_research WAT
$354.91
price up icon 1.40%
diagnostics_research LH
$256.98
price down icon 0.66%
$168.17
price up icon 2.44%
diagnostics_research MTD
$1,193.31
price up icon 0.04%
diagnostics_research IQV
$158.16
price down icon 0.35%
Kapitalisierung:     |  Volumen (24h):